STAT1 and acute myeloid leukemia: In addition, other factors may influence IL-6 levels in AML patients rather than STAT1/3 transcription downregulation by vitamin D [35], including the blast cell count and bone marrow niche micro-environment; that were incriminated in higher IL-6 levels in AML patients [7, 23, 49].